Home/Filings/4/0001213900-17-003341
4//SEC Filing

OptimizeRx Corp 4

Accession 0001213900-17-003341

$OPRXCIK 0001448431operating

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 5:05 PM ET

Size

4.6 KB

Accession

0001213900-17-003341

Insider Transaction Report

Form 4
Period: 2017-03-31
Transactions
  • Award

    Common Stock

    2017-03-31+6,250793,579 total
Footnotes (1)
  • [F1]The Issuer issued these shares to the Reporting Person under the Director Compensation Plan.

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001448431

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:05 PM ET
Size
4.6 KB